• Q&A

    The Promise of CRISPR

    Biochemist Samuel H. Sternberg describes the limitations, realities and potential of gene-editing technology.

    by Marci A. Landsmann

  • September 13: The Week in Cancer News

    Some cancer drugs being tested in clinical trials do not work the way researchers thought they did, and ringing a bell following radiation therapy may increase distress for patients.

    by Kate Yandell

  • HIV Can Worsen Cancer Treatment Outcomes

    People with HIV who develop certain cancers are more likely to die from them than patients without HIV—even if they receive similar treatment.

    by Jon Kelvey

  • Immunotherapy in the Elderly

    Immune checkpoint inhibitors can be effective treatments for elderly people with some types of advanced cancer, but more information is needed on their risks and benefits in this group.

    by Emma Yasinski

  • Why Is the Rate of Uterine Cancer Rising?

    Uterine cancer incidence is increasing in the U.S., particularly in Hispanic, Asian and black women, but obesity may play a smaller role in this change than was previously assumed.

    by Ashley P. Taylor

  • Cancer Care on a Native American Reservation

    For the first time, people living in the Navajo Nation who are diagnosed with cancer can get treated for the disease without leaving tribal lands.

    by Kate Yandell

  • Healthy Habits

    Overlooking Obesity

    Public awareness of the link between obesity and cancer risk is poor.

    by Jane C. Hu

  • Proton Therapy Is Associated With Reduced Side Effects

    When combined with chemotherapy, the newer form of radiation comes with fewer severe side effects than standard radiation therapy, a study suggests.

    by Sue Rochman

  • From the Editor-in-Chief

    Clonal Hematopoiesis: You Are Not the Same Person You Used to Be

    DNA sequencing of blood cells may provide clues for how cancer and other illnesses develop.

    by William G. Nelson, MD, PhD

  • The Right Dose

    Researchers want to find out when cancer patients can benefit from receiving lower doses of drugs or radiation, shortening treatment or skipping certain treatments altogether.

    by Kate Yandell